Clinical Trials Logo
  1. Home
  2. Cancer
  3. NCT04758338
  4. Details
NCT04758338 Clinical Trial

Enhancing Cancer Care Of Rural Dwellers

Cancer Clinical Trial

— ENCORE  

Official title:
Enhancing Cancer Care Of Rural Dwellers Through Telehealth and Engagement (ENCORE)

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT04758338
Other study ID # VICC PED 2013
Secondary ID R01CA240093-01
Status Recruiting
Phase N/A
First received
Last updated
Start date October 25, 2021
Est. completion date December 2031

Study information
Verified date November 2023
Source Vanderbilt-Ingram Cancer Center
Contact Emma Schremp
Phone (615)936-2156
Email emma.schremp@vumc.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Through a multi-level remote intervention, the Vanderbilt-Ingram Cancer Center (VICC) seeks to improve comprehensive cancer care delivery to patients residing in rural communities with persistent poverty. We plan to do this by using telehealth to broaden the reach of our NCI-designated comprehensive cancer center in these communities

Description:

Objectives: - Evaluate the clinical effectiveness of a multi-level telehealth-based intervention for rural hospitals consisting of provider access to tumor board expertise that incorporates disease, patient and molecular tumor characteristics, together with patient access to a supportive care intervention to improve cancer care delivery. - Evaluate the facilitators and barriers to future larger-scale dissemination and implementation of the multi-level intervention, designed to enhance quality rural cancer care delivery.

Recruitment information / eligibility
Status Recruiting
Enrollment 700
Est. completion date December 2031
Est. primary completion date December 2030
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years and older
Eligibility Inclusion Criteria: Provider and Patient: - At least 21 years of age or older and English speaking with the ability to provide informed consent - Oncology providers within designated VHAN oncology practices - Newly diagnosed or relapsed cancer patients of aforementioned oncology providers

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• VUMC telehealth services
Participants will access the CTS link (sent to them via email), which will connect them directly to a videoconference and enable them to see and hear the facilitators and other patients in the group.
• Interview
25-30 participants will be interviewed
• Educational materials
Participants will be provided educational materials

Locations
Country Name City State
United States Baptist Cancer Center- Bartlett Bartlett Tennessee
United States Baptist Cancer Center- Golden Triangle Columbus Columbus Mississippi
United States Ballad Health Systems Kingsport Tennessee
United States Vanderbilt-Ingram Cancer Center Nashville Tennessee
United States Baptist Cancer Center - North Mississippi Oxford Mississippi

Sponsors (2)
Lead Sponsor Collaborator
Debra Friedman National Cancer Institute (NCI)

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Measure the effectiveness of a multi-level telehealth-based intervention Approximately 3 years
Primary Estimate the facilitators to a future large-scale multi-level intervention Approximately 3 years
Primary Estimate the barriers to a future large-scale multi-level intervention Approximately 3 years
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients